Standard Investments’s Allergan plc AGN Stock Holding History

Standard Investments’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-46,800	Closed	-$11.3M	–	195
2014 Q3	$11.3M	Buy	+46,800	New	+$10.5M	0.6%	30

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Standard Investments's AGN Position: Q3 2017 in Review

Standard Investments sold out of Allergan plc (AGN) in Q3 2017, closing a stake of 194,589 shares — an estimated $47.3M sold.

Standard Investments first reported a position in AGN in Q2 2013 and held it in 17 quarters. The position peaked at $66.4M in Q1 2016. 1,090 funds tracked by Wall St. Rank hold AGN as of Q3 2017.

Standard Investments reported no remaining Allergan plc position as of Q3 2017 after selling out during the quarter.
Standard Investments sold 194,589 Allergan plc shares in Q3 2017, an estimated $47.3M.
Standard Investments first reported a position in Allergan plc in Q2 2013 and held it in 17 quarters.
Standard Investments's Allergan plc position peaked at $66.4M in Q1 2016.
1,090 funds tracked by Wall St. Rank held Allergan plc as of Q3 2017.

Based on Standard Investments's 13F filing for Q3 2017, filed 14 Nov 2017.